|
|
| DMF号:
7786 |
项目状态:I |
项目类型:II |
提交日期:1988-11-18 |
| 项目名称:D (+) GALACTOSE PRODUCT NO. G 0750 FD AS MFG. IN ST. LOIUS,MO |
| 项目持有人:
SIGMA F AND D DIV LTD
|
|
| DMF号:
8650 |
项目状态:I |
项目类型:II |
提交日期:1990-07-03 |
| 项目名称:GALACTOSE, THERAPEUTIC GRADE MANUFACTURED IN FEDERAL REPUBLIC OF GERMANY. |
| 项目持有人:
ROCHE DIAGNOSTICS GMBH
|
|
| DMF号:
10565 |
项目状态:A |
项目类型:II |
提交日期:1993-11-12 |
| 项目名称:EX-CELL 300 (MBS) W/L-GLUTAMINE, HEPES, NAHC03, GALACTOSE W/O PHENOL RED (CAT. NO. 14035) |
| 项目持有人:
SAFC BIOSCIENCES INC
|
|
| DMF号:
18625 |
项目状态:I |
项目类型:II |
提交日期:1993-09-03 |
| 项目名称:MURINE MONOCLONAL ANTIBODY (NR-LU-10)/STREPTAVADIN CONJUGATE LABELED W/RHENIUM-186 CONJUGATE (MAG2GABA), BIOTIN-GALACTOSE-HSA, INDIUM-111/YTTRIUM-90-DOTA-BIOTIN |
| 项目持有人:
NEORX CORP
|
|
| DMF号:
18650 |
项目状态:I |
项目类型:II |
提交日期:1998-01-12 |
| 项目名称:MURINE MONOCLONAL ANTIBODY (NR-LU-10)/STREPTAVIDIN CONJUGATE, BIOTIN-GALACTOSE-HUMAN SERUM ALBUMIN, YTTRIUM-Y-90-DOTA-BIOTIN |
| 项目持有人:
NEORX CORP
|
|
| DMF号:
18656 |
项目状态:I |
项目类型:II |
提交日期:1998-11-04 |
| 项目名称:INDIUM-IN-111 RADIOLABELED HUMANIZED MAB SINGLE CHAIN FV/STREPTAVIDIN FUSION PROTEIN (HUNRLU10 SCFV/SA), BIOTIN-GALACTOSE (SYNTHETIC), IN-111/Y-90-DOTA-BIOTIN |
| 项目持有人:
NEORX CORP
|
|
| DMF号:
28233 |
项目状态:A |
项目类型:IV |
提交日期:2014-04-25 |
| 项目名称:D-GALACTOSE, PLANT DERIVED, HIGH PURITY LOW ENDOTOXIN, USP/NF, EP (G-126-1) AS MANUFACTURED IN WAUKEGAN, IL |
| 项目持有人:
PFANSTIEHL INC
|
|
|
|
共有9条记录，1页，显示1-9 1
|
